Reversible Growth Hormone Excess in Two Girls with Neurofibromatosis Type 1 and Optic Pathway Glioma

Publisher： Karger

E-ISSN： 1663-2826|84|6|414-422

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.84, Iss.6, 2015-0, pp. : 414-422

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Growth Hormone Hypersecretion in a Girl with Neurofibromatosis Type 1 and an Optic Nerve Glioma: Resolution following Chemotherapy

By  

Hormone Research in Paediatrics, Vol. 53, Iss. 6, 2001-01 ,pp. : 305-308

Karger

Access to resources Recommend Favorite

Endocrine Long-Term Follow-Up of Children with Neurofibromatosis Type 1 and Optic Pathway Glioma


By  

Hormone Research in Paediatrics, Vol. 87, Iss. 3, 2017-03 ,pp. : 179-188

Karger

Access to resources Recommend Favorite

Growth Hormone Excess in Children with Optic Pathway Tumors Is a Transient Phenomenon

By  

Hormone Research in Paediatrics, Vol. 86, Iss. 1, 2016-06 ,pp. : 35-38

Karger

Access to resources Recommend Favorite

Growth Hormone and Neurofibromatosis

By  

Hormone Research in Paediatrics, Vol. 53, Iss. 1, 2004-11 ,pp. : 70-76

Karger

Access to resources Recommend Favorite

Combined Therapy with Insulin and Growth Hormone in 17 Patients with Type-1 Diabetes and Growth Disorders

By  

Hormone Research in Paediatrics, Vol. 82, Iss. 1, 2014-06 ,pp. : 53-58

Karger

Access to resources Recommend Favorite